MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cyclic glycine-proline increased in the cerebrospinal fluid of Parkinson’s patients after supplementation of blackcurrant anthocyanins: Potential biomarker for treatment

J. Guan, Y. Alamri, D. Fan, M. MacAskill, T. Anderson (Auckland, New Zealand)

Meeting: 2016 International Congress

Abstract Number: 880

Keywords: Amino acid disorders

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: We evaluated the changes of insulin-like growth factor-1 bioavailability in the Parkinson’s disease patients after 28 day supplementation of blackcurrant anthocyanin.

Background: Elevated insulin-like growth factor-1 in plasma is a biomarker for Parkinson’s disease associated insulin-like growth factor-1 resistant. Berry rich diet may be associated with low risk of Parkinson’s disease. The ratio cyclic Glycine-Proline / insulin-like growth factor-1 determines the bioavailability of insulin-like growth factor-1.

Methods: Both plasma and cerebrospinal fluid samples were collected from 11 Parkinson’s disease patients before and after 28 days supplementation of black current extracts in an open label study. The concentration of insulin like growth factor-1, cyclic Glycine-Proline, insulin-like growth factor-, insulin-like growth factor binding protein 1-3 were measured using ELISA and High Performance Liquid Chromatography mass spectrometry assay.

Results: Blackcurrant anthocyanin supplementation increased cerebrospinal fluid cyclic Glycine-Proline concentration, which was correlated to plasma cyclic Glycine-Proline concentration and cyclic Glycine-Proline / insulin-like growth factor-1 ratio in plasma. In contrast, the supplementation did not alter the concentration of insulin-like growth factor-1 and insulin-like growth factor binding proteins in both plasma and cerebrospinal fluid.

Conclusions: The increase of cyclic Glycine-Proline in the cerebrospinal fluid may be the result of autocrine regulation of insulin-like growth factor-1 in the plasma increasing bioavailability and a positive response to insulin-like growth factor-1 resistance in Parkinson’s disease patients. Thus, the change of cyclic Glycine-Proline and ratio of cyclic Glycine-Proline / insulin-like growth factor-1 may be a biomarker for insulin-like growth factor-1 function in Parkinson’s disease, which needs to be further evaluated in a larger study.

To cite this abstract in AMA style:

J. Guan, Y. Alamri, D. Fan, M. MacAskill, T. Anderson. Cyclic glycine-proline increased in the cerebrospinal fluid of Parkinson’s patients after supplementation of blackcurrant anthocyanins: Potential biomarker for treatment [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/cyclic-glycine-proline-increased-in-the-cerebrospinal-fluid-of-parkinsons-patients-after-supplementation-of-blackcurrant-anthocyanins-potential-biomarker-for-treatment/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cyclic-glycine-proline-increased-in-the-cerebrospinal-fluid-of-parkinsons-patients-after-supplementation-of-blackcurrant-anthocyanins-potential-biomarker-for-treatment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley